Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep Pyrosequencing.
St John EP, Simen BB, Turenchalk GS, Braverman MS, Abbate I, Aerssens J, Bouchez O, Gabriel C, Izopet J, Meixenberger K, Di Giallonardo F, Schlapbach R, Paredes R, Sakwa J, Schmitz-Agheguian GG, Thielen A, Victor M, Metzner KJ, Däumer MP; 454 HIV-1 Alpha Study Group. St John EP, et al. Among authors: daumer mp. PLoS One. 2016 Jan 12;11(1):e0146687. doi: 10.1371/journal.pone.0146687. eCollection 2016. PLoS One. 2016. PMID: 26756901 Free PMC article.
Therapeutic Drug Monitoring of Long-Acting Rilpivirine and Cabotegravir for Treatment of HIV-1 Infection-A Case Series of Five Patients With One Virologic Failure After Development of Two-Class Resistance.
Gerstenberg J, Klinker H, Baier M, von Braun A, Seybold U, Helbig C, Däumer M, Korn K, Stephan C, Schleenvoigt BT. Gerstenberg J, et al. Among authors: daumer m. Open Forum Infect Dis. 2024 Aug 23;11(9):ofae480. doi: 10.1093/ofid/ofae480. eCollection 2024 Sep. Open Forum Infect Dis. 2024. PMID: 39286033 Free PMC article.
A Randomized, Double-Blind, Placebo-Controlled, Short-Term Monotherapy Study of MK-6186, an HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor, in Treatment-Naïve HIV-Infected Participants.
Schürmann D, Hüser A, Pfäfflin F, Cilissen C, De Lepeleire I, Larson PJ, Anderson MS, Rizk ML, Hofmann J, Däumer M, Stegemann MS, Stoch SA, Wagner F, Iwamoto M. Schürmann D, et al. Among authors: daumer m. AIDS Res Hum Retroviruses. 2025 Jan;41(1):11-19. doi: 10.1089/AID.2023.0152. Epub 2024 Oct 3. AIDS Res Hum Retroviruses. 2025. PMID: 39291814 Clinical Trial.
Changes in real-world walking speed following 60-day bed-rest.
Grassi M, Von Der Straten F, Pearce C, Lee J, Mider M, Mittag U, Sies W, Mulder E, Daumer M, Rittweger J. Grassi M, et al. Among authors: daumer m. NPJ Microgravity. 2024 Jan 13;10(1):6. doi: 10.1038/s41526-023-00342-8. NPJ Microgravity. 2024. PMID: 38216584 Free PMC article.
Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 Omicron-Infected Immunocompromised Patients.
Gliga S, Lübke N, Killer A, Gruell H, Walker A, Dilthey AT, Thielen A, Lohr C, Flaßhove C, Krieg S, Pereira JV, Seraphin TP, Zaufel A, Däumer M, Orth HM, Feldt T, Bode JG, Klein F, Timm J, Luedde T, Jensen BO. Gliga S, et al. Among authors: daumer m. Clin Infect Dis. 2023 Feb 8;76(3):408-415. doi: 10.1093/cid/ciac802. Clin Infect Dis. 2023. PMID: 36189631 Free PMC article.
170 results